Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Wiener Klinische Wochenschrift|November 7, 2008
[Individualized management and therapy of myelodysplastic syndromes]Reinhard Stauder, Friedrich Wimazal, Thomas Nösslinger, et al.
Leukemia Research|December 3, 2014
Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendationsValeria Santini, Thomas Prebet, Pierre Fenaux, et al.
Leukemia Research|July 9, 2010
Practical use of azacitidine in higher-risk myelodysplastic syndromes: an expert panel opinionPierre Fenaux, David Bowen, Norbert Gattermann, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 13, 2003
Downregulation of carnitine acyltransferases and organic cation transporter OCTN2 in mononuclear cells in healthy elderly and patients with myelodysplastic syndromesHeidrun Karlic, Alfred Lohninger, Claudia Laschan, et al.
Annals of Hematology|March 25, 2006
Does mRNA level of microsomal carnitine palmitoyltransferase predict yield of peripheral blood stem cell apheresis?Michael Fillitz, Heidrun Karlic, Heinz Tüchler, et al.
Clinical Case Reports|May 3, 2021
CPX-351 (Vyxeos<sup>®</sup>) can cause severe rash in acute myeloid leukemia-A case reportRuth M Urbantat, Valentin Popper, Elisabeth Menschel, et al.
Critical Reviews in Oncology/Hematology|November 5, 2013
The role of epigenetics in the regulation of apoptosis in myelodysplastic syndromes and acute myeloid leukemiaHeidrun Karlic, Harald Herrmann, Franz Varga, et al.
Wiener Klinische Wochenschrift|November 26, 2014
10th anniversary of the Austrian MDS Platform: aims and ongoing projectsSonja Burgstaller, Peter Bettelheim, Otto Krieger, et al.
Pageof 6